Business context and reporting period
OmniLit Acquisition Corp. filed this unaudited Form 10-Q for the quarter and six months ended June 30, 2023. Although the request identifies Syntec Optics Holdings, Inc., the filing is OmniLit’s SPAC report, not Syntec Optics’ operating-company financial statements. OmniLit had not begun operating activities beyond seeking a business combination and reported no operating revenue.
On May 9, 2023, OmniLit agreed to merge with Syntec Optics, Inc. The proposed transaction would give Syntec equity holders 31.6 million OmniLit shares at a stated $10 per share. The agreement also provides for up to 26 million contingent earnout shares tied to post-closing share-price thresholds, and up to 2 million management performance shares tied to financial targets. Closing remained subject to conditions, including OmniLit stockholder approval, SEC clearance, expiration or termination of HSR waiting periods, and Nasdaq listing approval.
Financial performance and position
- Revenue and margins: No operating revenue was reported; margins are therefore not applicable. The company expected to generate operating revenue only after a business combination.
- Net results: Second-quarter 2023 net loss was $258,018, versus net income of $64,568 in Q2 2022. Six-month net loss was $470,665, versus a $107,349 loss in the first half of 2022. Six-month operating costs rose to $688,031 from $321,163; trust-account interest income increased to $302,669 from $220,201. Income-tax expense was $85,303 versus $6,387.
- Cash flow: Cash used in operating activities was $389,806 in the first half of 2023, compared with $319,178 in the prior-year period. Financing provided $740,061, including $694,941 borrowed from the Sponsor and a $45,120 transfer from the Trust Account for franchise-tax payments. Cash increased to $467,760 from $117,506 at December 31, 2022.
- Assets and liquidity: At June 30, 2023, total assets were $14.86 million, including $14.27 million held in the Trust Account and $467,760 of cash outside it. Current liabilities were $1.18 million; total liabilities were $1.68 million, including a $694,941 Sponsor note and $500,000 of deferred underwriters’ fees payable only if a business combination is completed. Stockholders’ deficit was $985,599.
- Debt and other metrics: The Sponsor note is unsecured, non-interest-bearing, and due at the business-combination closing. The filing reports no long-term debt or off-balance-sheet arrangements. No meaningful operating cash flow or operating margin is available for comparison.
Material changes versus prior comparable period
Compared with Q2 2022, OmniLit moved from net income to a net loss as operating costs and income-tax expense increased, while trust interest income declined for the quarter. For the six-month comparison, operating costs and net loss increased, though trust interest income was higher. Cash outside the Trust Account rose from $117,506 at year-end 2022, supported in part by Sponsor financing. Following 13,026,951 public-share redemptions in December 2022, 1,348,049 shares remained subject to possible redemption at June 30, 2023. The Sponsor also converted 4 million Class B shares into Class A shares during 2023.
Outlook, risks, contingencies, and unusual items
- Combination deadline and going concern: The extended deadline to complete a business combination was November 12, 2023. Management stated that failure to complete a transaction, absent an extension, would require liquidation and that the deadline raised substantial doubt about the company’s ability to continue as a going concern. Management also said it believed working capital and borrowing capacity would be insufficient to meet needs through the earlier of a business combination or one year from the filing. The filing’s liquidity discussion also says management did not believe additional funds would be needed, making its funding outlook internally mixed.
- Business-combination financing and dilution: Significant redemptions could require additional financing or debt to complete the transaction. The merger agreement’s earnout share issuances could substantially increase the share count if applicable conditions are met; the stated revenue and adjusted EBITDA earnout thresholds are transaction terms, not general company guidance.
- Controls: Management concluded disclosure controls and internal control over financial reporting were not effective at June 30, 2023, citing a material weakness involving technology-related general controls and consistent tax-provision reconciliation. Remediation steps were initiated, including enhanced written policies.
- Other risks: Sponsor indemnification for certain claims against the Trust Account may be difficult to collect; the company said it had not verified the Sponsor’s ability to pay. COVID-19 and the Russia-Ukraine conflict were noted as uncertainties with impacts not readily determinable. Management’s preliminary assessment was that the Inflation Reduction Act excise tax was not expected to have a material impact.
- Legal and accounting items: The company reported no material litigation and no material changes to previously disclosed risk factors. No market or interest-rate exposure was considered material given the short-term Treasury and money-market investments.
Important facts for investors to verify
- Confirm the transaction’s status, approvals, financing, redemption levels, and completion or extension relative to the November 12, 2023 deadline.
- Review Syntec Optics’ own financial statements and operating outlook; this filing reports OmniLit’s SPAC finances, not Syntec’s operating results.
- Assess the going-concern disclosure against available cash, Sponsor support, required transaction costs, and potential redemptions.
- Track remediation of the material weakness and whether subsequent filings report effective controls.
- Reconcile the Q2 net-loss figure: the financial statements report $258,018, while MD&A states $258,081.
- Verify the final treatment and potential dilution from the 31.6 million merger shares and contingent earnout arrangements.